349 related articles for article (PubMed ID: 32150864)
1. Cardiac Remodeling in Chronic Kidney Disease.
Kaesler N; Babler A; Floege J; Kramann R
Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32150864
[TBL] [Abstract][Full Text] [Related]
2. The guanylate cyclase C agonist linaclotide ameliorates the gut-cardio-renal axis in an adenine-induced mouse model of chronic kidney disease.
Nanto-Hara F; Kanemitsu Y; Fukuda S; Kikuchi K; Asaji K; Saigusa D; Iwasaki T; Ho HJ; Mishima E; Suzuki T; Suzuki C; Tsukimi T; Matsuhashi T; Oikawa Y; Akiyama Y; Kure S; Owada Y; Tomioka Y; Soga T; Ito S; Abe T
Nephrol Dial Transplant; 2020 Feb; 35(2):250-264. PubMed ID: 31411705
[TBL] [Abstract][Full Text] [Related]
3. Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy.
Law JP; Price AM; Pickup L; Radhakrishnan A; Weston C; Jones AM; McGettrick HM; Chua W; Steeds RP; Fabritz L; Kirchhof P; Pavlovic D; Townend JN; Ferro CJ
J Am Heart Assoc; 2020 Apr; 9(7):e016041. PubMed ID: 32212912
[TBL] [Abstract][Full Text] [Related]
4. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
[TBL] [Abstract][Full Text] [Related]
5. Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease.
Wollenhaupt J; Frisch J; Harlacher E; Wong DWL; Jin H; Schulte C; Vondenhoff S; Moellmann J; Klinkhammer BM; Zhang L; Baleanu-Curaj A; Liehn EA; Speer T; Kazakov A; Werner C; van der Vorst EPC; Selejan SR; Hohl M; Böhm M; Kramann R; Biessen EAL; Lehrke M; Marx N; Jankowski J; Maack C; Boor P; Prates Roma L; Noels H
Redox Biol; 2022 Oct; 56():102459. PubMed ID: 36099852
[TBL] [Abstract][Full Text] [Related]
6. Heart functional and structural compendium of cardiosplenic and cardiorenal networks in acute and chronic heart failure pathology.
Halade GV; Kain V; Ingle KA
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H255-H267. PubMed ID: 29101178
[TBL] [Abstract][Full Text] [Related]
7. Cardiorenal Syndrome Revisited.
Zannad F; Rossignol P
Circulation; 2018 Aug; 138(9):929-944. PubMed ID: 30354446
[TBL] [Abstract][Full Text] [Related]
8. Target organ cross talk in cardiorenal syndrome: animal models.
Bongartz LG; Braam B; Gaillard CA; Cramer MJ; Goldschmeding R; Verhaar MC; Doevendans PA; Joles JA
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1253-63. PubMed ID: 22914779
[TBL] [Abstract][Full Text] [Related]
9. Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease.
Uchida L; Tanaka T; Saito H; Sugahara M; Wakashima T; Fukui K; Nangaku M
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F388-F401. PubMed ID: 31841388
[TBL] [Abstract][Full Text] [Related]
10. RAAS inhibition and cardiorenal syndrome.
Onuigbo MA
Curr Hypertens Rev; 2014; 10(2):107-11. PubMed ID: 25549841
[TBL] [Abstract][Full Text] [Related]
11. Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome.
Liu S; Kompa AR; Kumfu S; Nishijima F; Kelly DJ; Krum H; Wang BH
Int J Cardiol; 2013 Oct; 168(3):1866-80. PubMed ID: 23347614
[TBL] [Abstract][Full Text] [Related]
12. Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway.
Deng T; Wei Z; Gael A; Deng X; Liu Y; Lai J; Hang L; Yan Q; Fu Q; Li Z
J Cardiovasc Pharmacol; 2020 Jun; 75(6):535-544. PubMed ID: 32168151
[TBL] [Abstract][Full Text] [Related]
13. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.
van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C
Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881
[TBL] [Abstract][Full Text] [Related]
14. Adenine-Induced Chronic Renal Failure in Rats: A Model of Chronic Renocardiac Syndrome with Left Ventricular Diastolic Dysfunction but Preserved Ejection Fraction.
Kashioulis P; Lundgren J; Shubbar E; Nguy L; Saeed A; Guron CW; Guron G
Kidney Blood Press Res; 2018; 43(4):1053-1064. PubMed ID: 29969785
[TBL] [Abstract][Full Text] [Related]
15. Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.
Guo J; Lu L; Hua Y; Huang K; Wang I; Huang L; Fu Q; Chen A; Chan P; Fan H; Liu ZM; Wang BH
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H1-H13. PubMed ID: 28411233
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of naringenin in cardiorenal syndrome.
Liu Y; An W; Gao A
J Surg Res; 2016 Jun; 203(2):416-23. PubMed ID: 27363651
[TBL] [Abstract][Full Text] [Related]
17. Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved.
Delgado-Valero B; Cachofeiro V; Martínez-Martínez E
Cells; 2021 Jul; 10(7):. PubMed ID: 34359993
[TBL] [Abstract][Full Text] [Related]
18. Apocynin improving cardiac remodeling in chronic renal failure disease is associated with up-regulation of epoxyeicosatrienoic acids.
Zhang K; Liu Y; Liu X; Chen J; Cai Q; Wang J; Huang H
Oncotarget; 2015 Sep; 6(28):24699-708. PubMed ID: 26322503
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease.
Beraldo JI; Benetti A; Borges-Júnior FA; Arruda-Junior DF; Martins FL; Jensen L; Dariolli R; Shimizu MH; Seguro AC; Luchi WM; Girardi ACC
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010001
[TBL] [Abstract][Full Text] [Related]
20. Accelerated renal fibrosis in cardiorenal syndrome is associated with long-term increase in urine neutrophil gelatinase-associated lipocalin levels.
Entin-Meer M; Ben-Shoshan J; Maysel-Auslender S; Levy R; Goryainov P; Schwartz I; Barshack I; Avivi C; Sharir R; Keren G
Am J Nephrol; 2012; 36(2):190-200. PubMed ID: 22889806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
